National Academies Press: OpenBook
« Previous: CONCLUSION
Suggested Citation:"APPENDIX." Institute of Medicine. 1994. Government and Industry Collaboration in AIDS Drug Development. Washington, DC: The National Academies Press. doi: 10.17226/9196.
×

Appendix

Workshop Program

Collaboration Between Government and Industry: Challenges and Opportunities for HIV Drug and Vaccine Development

May 6, 1994

9:00

Welcome and Introduction

  • Paul Volberding, Chief, AIDS Program and Clinical Oncology, San Francisco General Hospital, and Roundtable Cochair

9:15

Importance and Value of Government-Industry Collaboration on HIV Drug and Vaccine Development

  • Patrick Gage, Chief Operating Officer, Genetics Institute, Inc.

9:30

Historical Perspectives on Government Technology Transfer Policy and the Pharmaceutical Industry

Discussion Leader: Peter Barton Hutt, Partner, Covington & Burling

Understanding the Legislative History of Intellectual Property Rights Involving the Pharmaceutical Industry

  • Peter Barton Hutt, Partner, Covington & Burling

Understanding the History of Fair Pricing Clauses and Their Implementation in Government Licensing of Intellectual Property

  • Thomas Mays, Director, Office of Technology Development, National Cancer Institute

10:00

Discussion

10:30

Break

Suggested Citation:"APPENDIX." Institute of Medicine. 1994. Government and Industry Collaboration in AIDS Drug Development. Washington, DC: The National Academies Press. doi: 10.17226/9196.
×

10:45

Impediments to Collaboration on HIV Drug and Vaccine Development: Defining the Issues

Discussion Leader: Patrick Gage, Chief Operating Officer, Genetics Institute, Inc.

Commentary from a Government/NIH Perspective

  • Bruce Chabner, Director, Division of Cancer Treatment, National Cancer Institute

A View from the Pharmaceutical Industry

  • Stephen Carter, Senior Vice President, World Wide Clinical Research & Development, Bristol-Myers Squibb Pharmaceutical Research Institute

Practical Implications of Rules Governing Intellectual Property Developed from Collaborative Relationships

  • Harold Edgar, Professor of Law, Columbia University School of Law

11:30

Discussion

1:00

Lunch

2:00

Overcoming Obstacles to Collaboration and Promoting HIV Drug and Vaccine Development: Proposals for Resolution

Discussion Leader: Martin Delaney, Founding Director, Project Inform

Industry Perspective

  • David Barry, Group Director, Research, Development and Medical Affairs, The Wellcome Research Laboratories

Government/NIH Perspective

  • Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases

Congressional/Legislative Response

  • Timothy Westmoreland, Counsel, Subcommittee on Health and the Environment, U.S. House of Representatives

Suggested Citation:"APPENDIX." Institute of Medicine. 1994. Government and Industry Collaboration in AIDS Drug Development. Washington, DC: The National Academies Press. doi: 10.17226/9196.
×
 
  • David Schulke, Chief Health Policy Advisor, The Honorable Ron Wyden, U.S. House of Representatives, Member, Energy and Commerce Committee, Health and Environment Subcommittee

2:40

Discussion

4:15

Consideration of Future Directions: Summary of Salient Issues

  • Daniel Hoth, Senior Vice President and Chief Medical Officer, Cell Genesys

4:45

Closing Remarks

  • Barton Haynes, F.M. Hanes Professor of Medicine; Director, Duke University Arthritis Center; and Roundtable Cochair

5:00

Adjourn

Suggested Citation:"APPENDIX." Institute of Medicine. 1994. Government and Industry Collaboration in AIDS Drug Development. Washington, DC: The National Academies Press. doi: 10.17226/9196.
×
Page 18
Suggested Citation:"APPENDIX." Institute of Medicine. 1994. Government and Industry Collaboration in AIDS Drug Development. Washington, DC: The National Academies Press. doi: 10.17226/9196.
×
Page 19
Suggested Citation:"APPENDIX." Institute of Medicine. 1994. Government and Industry Collaboration in AIDS Drug Development. Washington, DC: The National Academies Press. doi: 10.17226/9196.
×
Page 20
Government and Industry Collaboration in AIDS Drug Development Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!